Article Processing Charge (APC) change!
Please note that there is an obligatory charge 200 EURO/1000 PLN for each manuscript submitted after January 1, 2024 and accepted for publication in Menopause Review/Przegląd Menopauzalny.
Aims and scope
Menopause Review/Przegląd Menopauzalny, quarterly, publishes articles on original research (experimental, clinical, laboratory), review papers and case studies of different medical specialties associated with the menopausal period of life. The journal also publishes letters to the Editor, reports and materials from scientific meetings, book reviews, and announcements of planned scientific congresses and conferences. Editors reserve the right to publish editorial commentaries on published works.
Papers should be submitted to the Editorial Office on-line via:
http://www.editorialsystem.com/pm/login/
Ethical requirements
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2000 (concerning the ethical principles for the medical community and forbidding releasing the name of the patient, initials or the hospital evidence number) and with the ethical standards of the responsible committee on human experimentation (institutional and national). The authors presenting case studies are obligated not to disclose patients' personal data. Regarding photographs, in case of any doubt that the picture inadequately protects the patient's anonymity his consent is required for publication.
Clinical trials
Menopause Review is published in accordance with ICMJE policies and recommendations. The ICMJE requires - and recommends that all medical journal editors require - registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for article publication.
The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, educational programs, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
The ICMJE accepts publicly accessible registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) that includes the minimum acceptable 24-item trial registration data set or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP.
In accordance with the ICMJE recommendations, the Editors of Menopause Review require authors to provide all necessary information regarding the registered study when submitting the article for publication: name of the register, Main ID, Public Title, Date of Registration. The data provided by the author are verified by the editors.
More information on this can be found here https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html
Source: ICMJE, Clinical Trials, https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html
Conflict of interest
Authors are expected to describe sources of the research funding, a role of the potential sponsor in planning, executing and analysis of the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflict of interest in relation to the submitted article should also be revealed.
Ghostwriting, guest authorship and plagiarism policy
Menopause Review/Przegląd Menopauzalny has procedures in place to prevent ghostwriting, guest authorship, and plagiarism.
Preparation of manuscripts
The paper should be written in English and be communicative, clear and concise, while maintaining the classic layout.
Original papers should be organized in a standard form with separate:
• Title
• Abstract
Each article should contain structured abstract (200–250 words), divided such as the text of the manuscript (Introduction, Material and methods, Results, Discussion, Conclusions).
• Key words
• Introduction
• Material and methods
• Results
• Discussion
• Conclusions
• Acknowledgements
• References
Review papers should follow the format for a regular article. Each article should contain unstructured abstract (100–150 words) and up to 5 key words.
Case reports should be divided to the following sections:
• Title
• Abstract
Each article should contain structured abstract (200–250 words), divided such as the text of the manuscript (Introduction, Material and methods, Results, Discussion, Conclusions).
• Key words
• Introduction
• Case report
• Conclusions
Letters to the editor may report original data or comment articles recently published our journal. All Letters to the editor are subject to editing and possible abridgment. Letters that report original data will be fully peer-reviewed.
Tables
Tables should be numbered according to their sequence in the text. The text should include references to all tables.
Each table should be provided in a separate file.
Illustrations
Each figure should be provided in a separate file, not included in the text.
Figures should preferably be provided in the TIF or EPS format. JPG is also acceptable.
All figures, whether photographs, graphs or diagrams, should be numbered consecutively throughout.
References
The reference list should be arranged in the order in which the citations appear in the text. The number of cited papers in original and review papers should not exceed 30 entries, and in case reports – 10. References should only be made to published titles.
Journal citation:
Sturdee DW, Pines A; International Menopause Society Writing Group, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011; 14: 302-320.
Journal with a supplement number:
Polgár C, Fodor J, Orosz Z, et al. Electron and brachytherapy boost in the conservative treatment of stage I–II breast cancer: 5-year results of the randomized Budapest boost trial. Radiother Oncol 2002; 62 (Suppl. 1): S15.
Journal with a part number:
McCormick MC, Kass B, Elixhauser A, Thompson J, Simpson L. Annual report on access to and utilization of health care for children and youth in the United States: 1999. Pediatrics 2000; 105 (1, pt 3): 219-230.
Online journal citation:
Keisch M, Arthur D, Patel R, et al. American Brachytherapy Society Breast Brachytherapy Task Group; http://www.americanbrachytherapy.org/guidelines/abs_breast_brachytherapy_taskgroup.pdf.
Electronic Publish Ahead of Print/DOI citation:
Kanis J, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteopor Int 2012; doi: 10.1007/s00 198-012-2074-y.
Book:
Bidzan M. Jakość życia pacjentek z różnym stopniem nasilenia wysiłkowego nietrzymania moczu. Impuls, Kraków 2008.
Chapter from a book:
van Leeuwen FE, Travis LB. Second cancers. In: Devita VT, ed. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005: 2575-2602.
In press:
Eisenberger MA, Blumenstein BA, Crawford ED, et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med In press.
The Publisher acquires all copyrights, on an exclusive basis, to manuscripts published, including the right to publish them in print, using electronic carriers or others, and on the Internet. Abstracts may be published without the Publisher’s permission.
Review Process
The registered manuscripts are sent to 2–3 independent experts for scientific evaluation. Submitted papers are accepted for publication after a positive opinion of the independent reviewers. Przegląd Menopauzalny/Menopause Review uses a double-blind review process in which authors do not know the identity of their reviewers, nor do the reviewers know the identities of the authors. The evaluation process usually takes 2–4 months.
Publication charges
Please be informed that a fee of EUR 100 will be charged for publication of an article in Menopause Review/Przegląd Menopauzalny.
Payments should be made on receipt of information that an article has been accepted for publication.
An invoice will be issued after the payment has been credited to our account. Termedia sp. z o.o. does not pay bank transfer costs.
PayPal (EUR) is the preferred way of payment. However, if this is impossible, payments can be made directly to the following bank accounts:
Payment in EUR:
PL 21 1090 1359 0000 0001 0601 0708
Termedia sp. z o.o.
ul. Kleeberga 8
61-615 Poznań
Santander Bank Polska S.A.
- SWIFT: WBKPPLPP
- amount: EUR 100
- title: Publication fee for ARTICLE- SIGNATURE
Payment in PLN:
PL 61 1090 1359 0000 0000 3505 2645
Termedia sp. z o.o.
ul. Kleeberga 8
61-615 Poznań
Santander Bank Polska S.A.
- SWIFT: WBKPPLPP
- amount: PLN 450
- title: Publication fee for ARTICLE-SIGNATURE
The fee applies only to the cost of preparing / developing the article for publication in the journal. The fee has no effect on the acceptance of the article for publication. All articles submit by editorial system are reviewed by independent experts outside the editorial office and based on their opinions are qualified or not for publication.
Please be informed that if the author decides not to publish the work, which was already accepted and paid, the fee paid will not be returned for reasons beyond the Publisher’s control.
